• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Ex-Insulet chief DeSisto out before he’s in at MannKind | Personnel Moves

Ex-Insulet chief DeSisto out before he’s in at MannKind | Personnel Moves

January 11, 2016 By Fink Densford

 

MassDevice.com Personnel MovesMannKind Corporation said today it withdrew an offer that would have made ex-Insulet (NSDQ:PODD) CEO Duane DeSisto its new CEO only 19 days after officially posting its offer to DeSisto.

The offer was withdrawn as objections were raised by DeSisto’s former employer Insulet, who said the new position would violate its non-competition agreement, which will be in effect until Sept. 17, 2016.

To fill the now empty spot, MannKind’s board tapped its CFO Matthew Pfeffer as the new chief exec, effective yesterday. Pfeffer will replace interim CEO Alfred Mann, who’s only held the spot since November.

“Matt has been a valuable member of the executive management of MannKind for many years and has been instrumental in managing our transition to a commercial stage operation. He understands the strategic and financial challenges that we face at this very important time for our company and has already begun to pursue a number of solutions,” MannKind lead director Kent Kresa said in a press release.

In addition, Pfeffer will fill a vacancy on the board that was slated to go to DeSisto, effective yesterday.

DeSisto served as prez and CEO of Insulet from 2003 to 2014, and held CFO and treasurer positions at the company prior to that. Before his time at Insulet, DeSisto worked at pulp and paper industry company PaperExchange.com, accessories wholesaler FGX International Holdings Limited and Zoll Medical.

 Cogentix Medical to promote Hammer to COO
Cogentix Medical (NSDQ:CGNT) said today it tapped Darin Hammers as its new COO, who’s promotion went into effect Jan. 4. The company also announced its CFO and SVP Brett Reynolds will resign, effective Jan. 28.
Read more

 Bioventus taps ex-Medtronic CEO Hawkins as manager board chair
Bioventus said today it appointed retired Medtronic (NYSE:MDT) CEO and chair Bill Hawkins as chair of the company’s board of managers. Hawkins will take the position from Dan Lemaitre, who has decided to leave the board.
Read more

 Ocular Therapeutix picks Talamo as chief medical officer
Ocular Therapeutix (NSDQ:OCUL) said today it named ophthalmologist Dr. Jonathan Talamo as its new chief medical officer, adding that Dr. Talamo would aid in advancing their Dextenza therapeutic candidate and other pipeline developments.
Read more

 Amazon seeks global healthcare leader
Amazon (NSDQ:AMZN) is looking for a new leader for its global healthcare biz, according to a job listing posted last month in the Seattle Times. The company said they are looking for someone to ‘redefine how healthcare companies procure the products and services they need and how manufacturers and sellers serve those customers.’
Read more

  • JenaValve taps Fauls as new regulator veep
  • Australia Medtech Services tags Reinander as Asia veep
  • Pathmaker names DiSanzo to board
  • BSN Medical appoints Healy as North American prez
  • Mauna Kea taps DeVivo for board

Filed Under: Business/Financial News Tagged With: Amazon, Australia Medtech Services, Bioventus LLC, BSN Medical, Cogentix Medical, Insulet, JenaValve, Mannkind Corp., Mauna Kea Technologies, oculartherapeutix, PathMaker Neurosystems Inc., Personnel Moves, Zoll Medical

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy